Michael Polansky, known for his work in tech investments and his partnership with Lady Gaga, is leading a secretive biotech startup called Outer Biosciences. The company is actively training artificial intelligence models using living human skin tissue sourced legally from surgical procedures, aiming to revolutionize biological research.
This initiative matters because traditional biology research is severely bottlenecked by the limitations of animal testing and lab-grown organoids, which rarely mimic real human physiology accurately. By bridging AI with living human tissue maintained outside the body, the company hopes to bypass traditional experimental ethics hurdles and accelerate medical breakthroughs.
Moving forward, Outer Biosciences plans to scale its tissue-sourcing pipeline to fuel advanced computational biology models. The venture highlights a growing convergence between deep tech infrastructure and life sciences, paving the way for data-driven drug discovery.
- Outer Biosciences trains AI models using living human skin tissue.
- Tissue is ethically sourced from surgical waste through vetted biobanks.
- The approach replaces inaccurate animal testing and simple cell cultures.
- The initiative aims to bridge the gap between AI and biological research.
Sources:
